Evidence map›Paper›PMID 17434559›Full record

ArticleVirology2007

Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.

Rajeev Kaul, Subhash C Verma, Erle S Robertson

Open access · greenAbstract read
In one paragraph

Article in Virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rajeev KaulDepartment of Microbiology and Tumor Virology Program of the Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Subhash C Verma
Erle S Robertson
University of Pennsylvania · US

Funding

Mechanisms of Action of LANA encoded by KSHVR01CA091792 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2002 to 2011
$3.4M
Mechanism of EBNA mediated cell migrationR01CA108461 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2004 to 2008
$1.7M
KSHV Latency control by RtaR01AI067037 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2006 to 2010
$1.6M
Role of EBNA3C in B Lymphocyte TransformationR01CA072150 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S · 2002 to 2006
$1.4M
EBV Associated Head and Neck CancersR01DE014136 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S · 2001 to 2005
$1.4M
Mechanism of KSHV reactivationR01DE017338 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S · 2005 to 2007
$811k
EBNA3C AND B LYMPHOCYTE TRANSFORMATIONR29CA072150 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBERTSON, ERLE S · 1996 to 2000
$46k
NCI NIH HHS CA072510NCI NIH HHS CA091792NCI NIH HHS CA108461NCI NIH HHS R01 CA072150NCI NIH HHS R01 CA091792NCI NIH HHS R01 CA108461NCI NIH HHS R29 CA072150NIAID NIH HHS AI067037NIAID NIH HHS R01 AI067037NIDCR NIH HHS DE01436NIDCR NIH HHS DE017338NIDCR NIH HHS R01 DE014136NIDCR NIH HHS R01 DE017338
6 · The paper itself

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the major biological cofactor contributing to development of Kaposi's sarcoma. KSHV establishes a latent infection in human B cells expressing the latency-associated nuclear antigen (LANA), a critical factor in the regulation of viral latency. LANA is known to modulate viral and cellular gene expression. We report here on some initial proteomic studies to identify cellular proteins associated with the amino and carboxy-terminal domains of LANA. The results of these studies show an association of known cellular proteins which support LANA functions and have identified additional LANA-associated proteins. These results provide new evidence for complexes involving LANA with a number of previously unreported functional classes of proteins including DNA polymerase, RNA helicase and cell cycle control proteins. The results also indicate that the amino terminus of LANA can interact with its carboxy-terminal domain. This interaction is potentially important for facilitating associations with other cell cycle regulatory proteins which include CENP-F identified in association with both the amino and carboxy-termini. These novel associations add to the diversity of LANA functions in relation to the maintenance of latency and subsequent transformation of KSHV infected cells.

Indexed as

Antigens, ViralBinding SitesCell Cycle ProteinsCell DivisionCell LineCytoskeletal ProteinsHerpesvirus 8, HumanHumansIn Vitro TechniquesMultiprotein ComplexesNuclear ProteinsProtein BindingProtein Structure, TertiaryRecombinant Fusion ProteinsSignal TransductionSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAntigens, ViralCell Cycle ProteinsCytoskeletal Proteinslatency-associated nuclear antigenMultiprotein ComplexesNuclear ProteinsRecombinant Fusion Proteins

Identifiers

PMID17434559
PMCPMC4067005
OpenAlexW2032130254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.